<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03400280</url>
  </required_header>
  <id_info>
    <org_study_id>W17.057</org_study_id>
    <secondary_id>UU2017-8272</secondary_id>
    <nct_id>NCT03400280</nct_id>
  </id_info>
  <brief_title>POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection</brief_title>
  <acronym>PORSCH</acronym>
  <official_title>POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection. a Nationwide Stepped-Wedge Cluster Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Antonius Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Antonius Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Nationwide stepped-wedge cluster randomized trial is designed to evaluate if the
      implementation of a best practice algorithm for postoperative care results in a decrease in
      incidence of major complications and death after pancreatic resection as compared to current
      practice.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale

      Pancreatic resection is a major abdominal operation with 50% chance of postoperative
      complications. A feared complication is severe pancreatic fistula, in which there is leakage
      of enzyme rich fluid into the abdominal cavity. Adequate complication management appears to
      be the most important factor in improving outcomes of patients undergoing pancreatic
      resection.

      Objective

      To investigate whether implementation of a best practice algorithm for postoperative care
      focusing on early detection and step-up management of postoperative pancreatic fistula
      results in a lower rate of major complications and death after pancreatic resection as
      compared to current practice

      Study design

      A nationwide stepped-wedge, cluster randomized, superiority trial. In this design all
      participating centers cross over from current practice to best practice according to the
      algorithm, but are randomized to determine the exact order. At the end of the trial, all
      centers will have implemented the best practice algorithm.

      Study population

      All centers performing pancreatic surgery in the Netherlands (i.e. the Dutch Pancreatic
      Cancer Group).

      Intervention

      Cluster level education on postoperative care according to a best practice algorithm,
      focusing on early detection and step-up management of postoperative pancreatic fistula. This
      algorithm is based on findings in Dutch observational cohort studies, systematic literature
      analyses, an inventory in current protocols on postoperative care and expert opinion. The
      proposed algorithm is validated in a multicenter cohort and consensus upon this algorithm is
      reached with pancreatic surgeons from all centers of the Dutch Pancreatic Cancer Group. The
      final algorithm was reviewed critically by the advisory committee of internationally
      respected experts in the field of pancreatology before implementation in this trial.

      Comparison

      Postoperative care according to current practice.

      Endpoints

      The primary outcome was measured in all patients undergoing pancreatic resection and is a
      composite of major complications (i.e. postpancreatectomy bleeding, new-onset organ failure
      and death). Secondary endpoints include the individual components of the primary endpoint and
      other clinical outcomes, number of patients receiving adjuvant chemotherapy, healthcare
      resource utilization and costs analysis. Follow-up will be 90 days after pancreatic
      resection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">February 9, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 9, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Stepped-wedge cluster randomized trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite primary endpoint</measure>
    <time_frame>90 days after index pancreatic resection</time_frame>
    <description>The primary endpoint of this trial is a composite of the most severe complications associated to postoperative pancreatic fistula. This endpoint will be considered positive if one of the following complications occurs within 90 days after pancreatic resection: late postpancreatectomy bleeding, new-onset organ failure and/or death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative mortality</measure>
    <time_frame>90 days after index pancreatic resection</time_frame>
    <description>Measured as rate of death at 90-day follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New-onset organ failure</measure>
    <time_frame>90 days after index pancreatic resection</time_frame>
    <description>Measured as organ failure occuring any time within 90 days after resection, not present at time of index pancreatic resection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late postpancreatectomy bleeding</measure>
    <time_frame>90 days after index pancreatic resection</time_frame>
    <description>Defined in accordance to the International Study Group on Pancreatic Surgery (ISGPS) definition as bleeding occurring any time after 24 hours after pancreatic resection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative morbidity</measure>
    <time_frame>90 days after index pancreatic resection</time_frame>
    <description>Including complications according to the Clavien-Dindo system and pancreatectomy specific complications according to the ISGPS definitions (e.g. postpancreatectomy bleeding, postoperative pancreatic fistula, postoperative bile leak, postoperative chyle leak and delayed gastric emptying).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adjuvant chemotherapy</measure>
    <time_frame>90 days after index pancreatic resection</time_frame>
    <description>Measured as number of patients receiving adjuvant chemotherapy at 90-day follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success of implementation</measure>
    <time_frame>90 days after index pancreatic resection</time_frame>
    <description>Measured as number of patients in whom the algorithm was not followed and timing of abdominal CT scans in both strategies.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>90 days after index pancreatic resection</time_frame>
    <description>Calculated by comparing health effects and medical costs related to both strategies up to 90 days after pancreatic resection.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Pancreatic Diseases</condition>
  <condition>Pancreatic Neoplasms</condition>
  <condition>Pancreatic Cancer</condition>
  <condition>Pancreatitis</condition>
  <arm_group>
    <arm_group_label>Best practice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Postoperative care according to a best practice algorithm for postoperative care focussing on early detection and minimally invasive management of postoperative pancreatic fistula.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Current practice</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Postoperative care according to current usual practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Best practice algorithm for postoperative care</intervention_name>
    <description>See arm/group description</description>
    <arm_group_label>Best practice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Clusters:

          -  All Dutch centers performing pancreatic surgery (i.e. performing at least 20
             pancreatoduodenectomies a year)

        Exclusion Criteria for Clusters:

        Inclusion Criteria for Patients:

          -  Patients underoging pancreatic resection for any indication

        Exclusion Criteria for Patients:

          -  None (i.e. complete enumeration)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Quintus Molenaar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hjalmar C van Santvoort, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Antonius Ziekenhuis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jasmijn Smits, MD</last_name>
    <phone>+31887571207</phone>
    <email>porsch@dpcg.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hjalmar C van Santvoort, MD, PhD</last_name>
    <phone>+31887556489</phone>
    <email>h.vansantvoort@umcutrecht.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jeroen Bosch Ziekenhuis</name>
      <address>
        <city>'s Hertogenbosch</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koop Bosscha</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Besselink</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouwen Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastiaan Festen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>VUmc</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geert Kazemier</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amphia ziekenhuis</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Schreinemakers</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Reinier de Graaf gasthuis</name>
      <address>
        <city>Delft</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daphne Roos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catharina ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignace de Hingh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mike Liem</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMCG</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent de Meijer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tjongerschans</name>
      <address>
        <city>Heerenveen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fennie Wit</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>LUMC</name>
      <address>
        <city>Leiden</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bert Bonsing</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maastricht UMC</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald van Dam</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radboud UMC</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion van der Kolk</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus MC</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Casper van Eijck</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maasstad ziekenhuis</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erwin van der Harst</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>RAKU (St. Antonius ziekenhuis &amp; UMC Utrecht)</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hjalmar van Santvoort</last_name>
    </contact>
    <contact_backup>
      <last_name>Quintus Molenaar</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Isala klinieken</name>
      <address>
        <city>Zwolle</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gijs Patijn</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2017</study_first_submitted>
  <study_first_submitted_qc>January 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Antonius Hospital</investigator_affiliation>
    <investigator_full_name>HC van Santvoort</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Postoperative pancreatic fistula</keyword>
  <keyword>Pancreatic resection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The datasets generated during and/or analysed during the current study are/will be available upon request from Hjalmar van Santvoort (h.van.santvoort@antoniusziekenhuis.nl)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

